Evofem Biosciences, Inc. signed an exclusive distributorship agreement on April 24, 2026, with Clovis Davis Pharmaceuticals to promote and sell the product SOLOSEC in Sub-Saharan Africa for five years. This event is significant for the company's market expansion efforts and has a positive sentiment from an equity investor perspective.